C62.9 Categoría · se requiere mayor especificidad Malignant neoplasm of testis, unspecified whether descended or undescended
ICD-10-CM C62.9 identifies “Malignant neoplasm of testis, unspecified whether descended or undescended” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Capítulo 2: Neoplasms
Instrucciones del código
Sin notas adicionales.
Instrucciones de niveles superiores
C62 · Malignant neoplasm of testis
Use additional code1
code to identify any functional activity
Capítulos 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C60-C63 · Malignant neoplasms of male genital organs (C60-C63)
Includes1
malignant neoplasm of skin of male genital organs
Códigos más específicos
C62.90Malignant neoplasm of unspecified testis, unspecified whether descended or undescendedCódigo facturable y específicoC62.91Malignant neoplasm of right testis, unspecified whether descended or undescendedCódigo facturable y específicoC62.92Malignant neoplasm of left testis, unspecified whether descended or undescendedCódigo facturable y específicoReferencias del índice oficial
Referencias del índice oficial (11)
Embryoma (2)
- Embryoma › malignant › testisÍndice de enfermedades
- Embryoma › testisÍndice de enfermedades
Leydig cell (2)
- Leydig cell › carcinoma › unspecified site › maleÍndice de enfermedades
- Leydig cell › tumor › malignant › unspecified site › maleÍndice de enfermedades
Neoplasm, neoplastic (2)
Orchioblastoma (1)
- OrchioblastomaÍndice de enfermedades
Seminoma (1)
- SeminomaÍndice de enfermedades
Sertoli cell (1)
- Sertoli cell › carcinoma › unspecified site(male)Índice de enfermedades
Spermatocytoma (1)
- SpermatocytomaÍndice de enfermedades
Teratoma(solid) (1)
- Teratoma(solid) › testisÍndice de enfermedades
Referencias desde otros códigos (1)
Excludes 1 · male choriocarcinoma NOS (C62.9-)
Historial
Historial del código
Sin cambios desde la primera aparición
ModificadoSin cambios
FY2016
Vigente desde
- Primera aparición
Malignant neoplasm of testis, unspecified whether descended or undescended
Categoría — seleccione un código más específico
CDC/NCHS · FY2016Todas las ediciones (19)
| Todas las ediciones | Vigente desde | Historial del código |
|---|---|---|
| FY2016 | 2015-10-01 | Primera aparición |
| FY2017 | 2016-10-01 | Sin cambios tabulares |
| FY2018 | 2017-10-01 | Sin cambios tabulares |
| FY2019 | 2018-10-01 | Sin cambios tabulares |
| FY2020 | 2019-10-01 | Sin cambios tabulares |
| FY2020 · April | 2020-04-01 | Sin cambios tabulares |
| FY2021 | 2020-10-01 | Sin cambios tabulares |
| FY2021 · 01-01 | 2021-01-01 | Sin cambios tabulares |
| FY2022 | 2021-10-01 | Sin cambios tabulares |
| FY2022 · 04-01 | 2022-04-01 | Sin cambios tabulares |
| FY2023 | 2022-10-01 | Sin cambios tabulares |
| FY2023 · 04-01 | 2023-04-01 | Sin cambios tabulares |
| FY2024 | 2023-10-01 | Sin cambios tabulares |
| FY2024 · 04-01 | 2024-04-01 | Sin cambios tabulares |
| FY2025 | 2024-10-01 | Sin cambios tabulares |
| FY2025 · 04-01 | 2025-04-01 | Sin cambios tabulares |
| FY2026 | 2025-10-01 | Sin cambios tabulares |
| FY2026 · April | 2026-04-01 | Sin cambios tabulares |
| FY2027 | 2026-10-01 | Sin cambios tabulares |
Explora los códigos más específicos de esta categoría. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.